A Study to Evaluate Safety and Efficacy of TTP054 for 12 Weeks in Subjects With Type 2 Diabetes

NCT01665352 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

186

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: TTP054
DRUG: Placebo

Sponsor

vTv Therapeutics